Down-Regulation of Lncrna MALAT1 Attenuates Neuronal Cell Death Through Suppressing Beclin1-Dependent Autophagy by Regulating Mir-30a in Cerebral Ischemic Stroke

• Published in: Cellular physiology and biochemistry Vol. 43; no. 1; pp. 182 - 194
• Main Authors: Guo, Dong, Ma, Ji, Yan, Lei, Li, Tengfei, Li, Zhiguo, Han, Xinwei, Shui, Shaofeng
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.01.2017; Cell Physiol Biochem Press GmbH & Co KG
• Subjects: Adenine - analogs & derivatives; Adenine - toxicity; Animals; Apoptosis; Apoptosis - drug effects; Autophagy; Autophagy - drug effects; Beclin-1 - antagonists & inhibitors; Beclin-1 - genetics; Beclin-1 - metabolism; Beclin1; Brain; Breast cancer; Carotid arteries; Cell cycle; Cell death; Cells, Cultured; Cerebral Cortex - metabolism; Cerebral Cortex - pathology; Cerebral ischemic stroke; Disease Models, Animal; Down-Regulation - drug effects; Gene expression; Glucose; Glucose - pharmacology; Infarction, Middle Cerebral Artery - metabolism; Infarction, Middle Cerebral Artery - pathology; Ischemia; Lncrna MALAT1; Lung cancer; Metastasis; Mice; Mice, Inbred C57BL; MicroRNAs - chemistry; MicroRNAs - genetics; MicroRNAs - metabolism; MiR-30a; Neuronal cell death; Neurons - cytology; Neurons - drug effects; Neurons - metabolism; Neurosciences; Original Paper; Oxygen - metabolism; Pathogenesis; Proteins; RNA Interference; RNA, Long Noncoding - antagonists & inhibitors; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism; Stroke; Stroke - metabolism; Stroke - pathology; Up-Regulation - drug effects; United States > US; MiR-30a; Beclin1; Lncrna MALAT1; Autophagy; Neuronal cell death; Cerebral ischemic stroke
• ISSN: 1015-8987; 1421-9778
• DOI: 10.1159/000480337

Background/Aims: LncRNA metastasis associated lung adenocarcinoma transcript 1 (MALAT1) was reported to be highly expressed in an in vitro mimic of ischemic stroke conditions. However, the exact biological role of MALAT1 and its underlying mechanism in ischemic stroke remain to be elucidated. Methods: The roles of MALAT1 and miR-30a on cell death and infarct volume and autophagy were evaluated in experimental ischemic stroke. The relationships between miR-30a and MALAT1, Beclin1 were confirmed by luciferase reporter assay. The autophagy inhibitor 3-methyadenine (3-MA) was used to examine the impact of autophagy on ischemic injury. Results: We found that MALAT1, along with the levels of conversion from autophagy-related protein microtubule-associated protein light chain 3-I (LC3-I) to LC3-phosphatidylethanolamine conjugate (LC3-II), as well as Beclin1 were up-regulated and miR-30a was down-regulated in cerebral cortex neurons after oxygen-glucose deprivation (OGD) and mouse brain cortex after middle cerebral artery occlusion-reperfusion (MCAO). Down-regulation of MALAT1 suppressed ischemic injury and autophagy in vitro and in vivo. Furthermore, MALAT1 may serve as a molecular sponge for miR-30a and negatively regulate its expression. In addition, MALAT1 overturned the inhibitory effect of miR-30a on ischemic injury and autophagy in vitro and in vivo, which might be involved in the derepression of Beclin1, a direct target of miR-30a. Mechanistic analyses further revealed that autophagy inhibitor 3-methyadenine (3-MA) markedly suppressed OGD-induced neuronal cell death and MCAO-induced ischemic brain infarction. Conclusion: Taken together, our study first revealed that down-regulation of MALAT1 attenuated neuronal cell death through suppressing Beclin1-dependent autophagy by regulating miR-30a expression in cerebral ischemic stroke. Besides, our study demonstrated a novel lncRNA-miRNA-mRNA regulatory network that is MALAT1-miR-30a-Beclin1 in ischemic stroke, contributing to a better understanding the pathogenesis and progression of ischemic stroke.